Research on the Development of Antigen Immunoassay Technology Based on Patent Information
10.13748/j.cnki.issn1007-7693.20222370
- VernacularTitle:基于专利信息的抗原免疫检测技术发展研究
- Author:
ZOU Yue
1
,
2
;
YOU Jin
1
,
2
;
QIAO Zhiwei
1
,
2
;
LI Yang
1
,
2
;
LI Hongyu
1
,
2
,
3
Author Information
1. Lanzhou University, School of Pharmacy, Lanzhou, 730000, China
2. Lanzhou University, Technology and Innovation Support Center, Lanzhou, 730000, China
3. Lanzhou University, School of Life Sciences, Lanzhou, 730000, China
- Publication Type:Journal Article
- Keywords:
antigen detection;
patent analysis;
research and development strategy;
layout strategy
- From:
Chinese Journal of Modern Applied Pharmacy
2023;40(13):1858-1868
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE To analyze technical and legal information of patents in the field of antigen immunoassay technology, and to provide advice to related enterprises on R&D direction and patent layout. METHODS Using patent analysis means combined with data visualization presentation, the R&D trends and research hotspots in the field of immunoassays of Abbott, Wondfo Bio, BGI Genomics and other related companies were systematically analyzed. RESULTS Abbott's patent layout in the field of immunoassay was more comprehensive and occupied a dominant position in international competition. Although the immunoassay technologies of Chinese enterprises had their own expertise, the industrial layout and the comprehensiveness of patent layout were weak. CONCLUSION Chinese enterprises should strengthen interdisciplinary research and strive for breakthroughs in the direction of cutting-edge technologies such as multiplex multi-pathogen high-throughput detection, magnetic particle chemiluminescence detection and microfluidic chip detection, as well as choosing appropriate patent protection strategies considering their own characteristics.